Prof. Dr. Doğan Uncu

Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study)

Clinical & Translational Oncology, 2026

DOI 10.1007/s12094-026-04494-3 PMID 42400766 Source: OpenAlex

Effects of Immersive Virtual Reality and Relaxation Video on Symptom Severity, Distress, and Quality of Life in Lung Cancer Patients During Initial Chemotherapy Cycles: A Three-Arm Randomised Controlled Trial

Healthcare, 2026

DOI 10.3390/healthcare14203394 PMID 42940439 Open-access full textSource: ORCID

Clinicopathological Features of Intrahepatic Cholangiocarcinoma with Assessment of IDH1 Mutation: A Two-Center Retrospective Study

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15135290 PMID 42452749 Open-access full textSource: ORCID

A Machine Learning Framework for Prognostic Modeling in Stage III Colon Cancer

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15083091 PMID 42074893 Open-access full textSource: ORCID

Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG)

Cancers, 2026

DOI 10.3390/cancers18030394 PMID 41681877 1 citation (Europe PMC) Open-access full textSource: ORCID

Neoadjuvant chemotherapy with surgery versus concurrent chemoradiation in N2 non-small cell lung cancer: a retrospective comparative analysis of treatment outcomes

Turkish Journal of Clinics and Laboratory, 2026

DOI 10.18663/tjcl.1837114 Open-access full textSource: OpenAlex

Machine learning–based prediction of recurrence after curative resection in non–small cell lung cancer

Scientific Reports, 2026

DOI 10.1038/s41598-026-47862-3 PMID 41957214 Open-access full textSource: OpenAlex

Prediction of postoperative recurrence in non–small cell lung cancer using machine learning approaches.

Journal of Clinical Oncology, 2026

DOI 10.1200/jco.2026.44.16_suppl.e20020 Source: OpenAlex

Histological Grade, Tumor Size, and Surgical Margins as Key Predictors in Soft Tissue Sarcoma Outcomes: A Retrospective Cohort Analysis

Indian Journal of Surgical Oncology, 2026

DOI 10.1007/s13193-026-02607-6 Source: ORCID

Long-term cardiotoxicity outcomes of trastuzumab and cardiac safety of novel HER2-targeted therapies

Expert Opinion on Drug Safety, 2026

DOI 10.1080/14740338.2026.2667402 PMID 42080343 1 citation (OpenAlex) Source: OpenAlex

Recurrence of Adult Granulosa Cell Tumors: The Factors Affecting Secondary Recurrence and Survival After Recurrence

Journal of Cancer, 2026

DOI 10.7150/jca.127596 PMID 41869453 Open-access full textSource: OpenAlex

Real-life data on adjuvant trastuzumab emtansine treatment in early-stage HER2-positive breast cancer: a Turkish Oncology Group study

Anti-Cancer Drugs, 2025

DOI 10.1097/cad.0000000000001717 PMID 40162996 1 citation (Europe PMC) Open-access full textSource: OpenAlex

Assessing the Efficacy and Safety of Shorter versus Extended Adjuvant Treatment Duration for Stage III Low-Risk Colon Cancer: A Comparative Analysis

Nigerian Journal of Clinical Practice, 2025

DOI 10.4103/njcp.njcp_848_23 PMID 40326903 Open-access full textSource: OpenAlex

Long-Term Outcomes of Patients Undergoing Conversion Surgery After Induction Chemotherapy: Turkish Oncology Group Study

Medicina, 2025

DOI 10.3390/medicina61050776 PMID 40428735 Open-access full textSource: OpenAlex

The frequency of driver mutations in non-small cell lung cancer patients: The Turkish nation-wide, observational, Registurk-Lung study (updated analysis).

Journal of Clinical Oncology, 2025

DOI 10.1200/jco.2025.43.16_suppl.e20501 Open-access full textSource: OpenAlex

Elderly Men with De Novo Metastatic Castration-Sensitive Prostate Cancer: Therapy and Does Comorbidity Matter

Medicina, 2025

DOI 10.3390/medicina61112068 PMID 41303903 Open-access full textSource: ORCID

Anorectal Malignant Melanoma: Diagnostic Pitfalls and Prognostic Insights from a Single-Center Retrospective Analysis

Diagnostics, 2025

DOI 10.3390/diagnostics15162086 PMID 40870938 2 citations (Europe PMC) Open-access full textSource: ORCID

Illuminating Bilateral Breast Cancer: A Multicenter Experience and Clinical Observations

Medicina, 2025

DOI 10.3390/medicina61061029 PMID 40572717 4 citations (Europe PMC) Open-access full textSource: ORCID

Induction or Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer Receiving Chemoradiotherapy? A Turkish Oncology Group Study

Journal of Clinical Medicine, 2025

DOI 10.3390/jcm14124189 PMID 40565933 Open-access full textSource: ORCID

Prognostic Factors and Long-Term Survival in Kaposi’s Sarcoma Patients: Results from a 28-Year Retrospective Cohort

Medicina, 2025

DOI 10.3390/medicina61040724 PMID 40283016 1 citation (Europe PMC) Open-access full textSource: ORCID

A New Prognostic Indicator for Biliary Tract Cancers: The ABIC Score

Current Oncology, 2025

DOI 10.3390/curroncol32040200 PMID 40277757 2 citations (Europe PMC) Open-access full textSource: ORCID

Thiol-disulfide homeostasis and ischemia modified albumin levels in patients diagnosed with ovary carcinoma

Scientific reports, 2025

DOI 10.1038/s41598-025-04608-x PMID 40473830 1 citation (Europe PMC) Open-access full textSource: Europe PMC

Comparative efficacy of adjuvant FOLFOX vs. FLOT following neoadjuvant FLOT in patients with locally advanced gastric cancer

Turkish journal of medical sciences, 2025

DOI 10.55730/1300-0144.6002 PMID 40686717 Open-access full textSource: Europe PMC

Survival advantage of bevacizumab rechallenge in recurrent ovarian cancer regardless of platinum sensitivity

Anti-Cancer Drugs, 2025

DOI 10.1097/cad.0000000000001798 PMID 41430637 1 citation (OpenAlex) Source: OpenAlex

When location meets biology: combined risk patterns drive outcomes in primary central nervous system lymphoma

Turkish Journal of Clinics and Laboratory, 2025

DOI 10.18663/tjcl.1761637 1 citation (OpenAlex) Open-access full textSource: OpenAlex

CDK4-6 Inhibitors: Evaluation of Efficacy in Cases of Hormone Receptor-Positive HER2-Negative Breast Cancer with Only Bone Metastasis

Journal of Oncological Sciences, 2025

DOI 10.37047/jos.galenos.2024.2024.103871 Open-access full textSource: OpenAlex

Clinicopathological Features and Treatment Outcomes of Gestational Trophoblastic Disease: A Retrospective Study From A Tertiary Care Center in Türkiye

Ankara City Hospital Medical Journal, 2025

DOI 10.5505/achmedj.2025.25633 Open-access full textSource: OpenAlex

Is maintenance chemotherapy always necessary in gestational trophoblastic neoplasia? A retrospective cohort analysis

The European Research Journal, 2025

DOI 10.18621/eurj.1754019 Open-access full textSource: OpenAlex

Risk-Based Evaluation of Adjuvant Chemotherapy in Stage I Epithelial Ovarian Cancer: A Retrospective Cohort Study

Acta haematologica oncologica Turcica., 2025

DOI 10.4274/ahot.galenos.2025.2025-6-8 Open-access full textSource: OpenAlex

Comparison of the Efficacy of First-Line Pemetrexed-Platinum and Gemcitabine-Platinum Regimens in Malignant Peritoneal Mesothelioma

Clinical Medicine Insights Oncology, 2025

DOI 10.1177/11795549251385075 PMID 41133016 Open-access full textSource: OpenAlex

The Impact of Sodium on Prognosis in RCC and NSCLC Patients Receiving Second-line Nivolumab Treatment

Journal of Oncological Sciences, 2025

DOI 10.37047/jos.galenos.2025.2025-8-12 Open-access full textSource: OpenAlex

Comparative Outcomes of Surgery and Chemoradiotherapy After Neoadjuvant Chemotherapy in Stage II–III Bladder Cancer

The European Research Journal, 2025

DOI 10.18621/eurj.1807684 Open-access full textSource: OpenAlex

Predicting hepatocellular carcinoma survival with artificial intelligence

Scientific Reports, 2025

DOI 10.1038/s41598-025-90884-6 PMID 39979406 30 citations (OpenAlex) Open-access full textSource: OpenAlex

Predicting survival outcomes in advanced pancreatic cancer using machine learning methods

Medicine, 2025

DOI 10.1097/md.0000000000043904 PMID 40826793 4 citations (OpenAlex) Open-access full textSource: OpenAlex

The predictive value of sarcopenia and PET imaging metrics in metastatic non-squamous NSCLC

Biomarkers in Medicine, 2025

DOI 10.1080/17520363.2025.2540758 PMID 40753467 1 citation (OpenAlex) Open-access full textSource: OpenAlex

Comparison of clinical, pathological, and prognostic features of small bowel tumors

Oncology in Clinical Practice, 2025

DOI 10.5603/ocp.102621 Open-access full textSource: OpenAlex

Menopausal Status at Diagnosis is a Prognostic Indicator in Patients who are Operated for Uterine Carcinosarcoma

Journal of Ankara University Faculty of Medicine, 2025

DOI 10.4274/atfm.galenos.2025.79058 Open-access full textSource: OpenAlex

2079eP The NLA score as a prognostic biomarker in advanced driver-negative NSCLC treated with immunotherapy-based strategies

Annals of Oncology, 2025

DOI 10.1016/j.annonc.2025.08.2700 1 citation (OpenAlex) Open-access full textSource: OpenAlex

Comparative efficacy of adjuvant FOLFOX versus FLOT following neoadjuvant FLOT in locally advanced gastric cancer.

Journal of Clinical Oncology, 2025

DOI 10.1200/jco.2025.43.16_suppl.e16120 Open-access full textSource: OpenAlex

P2.10.02 Developments in Treatment of Non-Small Cell Lung Cancer and Their Implications for National Practice.Registurk-Lung National Registry Study

Journal of Thoracic Oncology, 2025

DOI 10.1016/j.jtho.2025.09.696 Open-access full textSource: OpenAlex

The effect of an interactive nurse support program developed with a mobile application on patient outcomes in breast cancer patients who received outpatient chemotherapy: A randomized controlled trial

European Journal of Oncology Nursing, 2025

DOI 10.1016/j.ejon.2025.102882 PMID 40185060 7 citations (OpenAlex) Source: OpenAlex

The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Perometer and Circumferential Measurements: Relationship with Functional Status and Quality of Life

Lymphatic Research and Biology, 2025

DOI 10.1089/lrb.2024.0008 PMID 39761071 3 citations (OpenAlex) Source: OpenAlex

123P The effect of immersive virtual reality and relaxing video interventions on symptom severity, distress and quality of life in lung cancer patients undergoing chemotherapy: A preliminary results of a randomised controlled trial

ESMO Real World Data and Digital Oncology, 2025

DOI 10.1016/j.esmorw.2025.100320 Open-access full textSource: OpenAlex

Efficacy and Safety of Bevacizumab in Patients with Low-Grade Serous Ovarian Cancer

Future Oncology, 2024

DOI 10.2217/fon-2023-0763 PMID 38328890 Source: OpenAlex

The results of adding immunotherapy to chemotherapy in patients with small cell lung cancer: Registurk-Lung study—Real-world data.

Journal of Clinical Oncology, 2024

DOI 10.1200/jco.2024.42.16_suppl.e20006 Open-access full textSource: OpenAlex

Superiority of Pathologic Lymph Node Ratio over Positive Lymph Node Count in Operated Early-Stage Breast Cancer

Annali Italiani di Chirurgia, 2024

DOI 10.62713/aic.3319 PMID 39723526 1 citation (Europe PMC) Open-access full textSource: ORCID

Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer

Journal of Clinical Medicine, 2024

DOI 10.3390/jcm14010173 PMID 39797256 2 citations (Europe PMC) Open-access full textSource: ORCID

Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms

Cancer investigation, 2024

DOI 10.1080/07357907.2024.2330102 PMID 38486421 1 citation (Europe PMC) Source: Europe PMC

Defining the relationship between ovarian adult granulosa cell tumors and synchronous endometrial pathology: Does ovarian tumor size correlate with endometrial cancer?

The journal of obstetrics and gynaecology research, 2024

DOI 10.1111/jog.15896 PMID 38304973 1 citation (Europe PMC) Open-access full textSource: Europe PMC

The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer

Oncology, 2024

DOI 10.1159/000540517 PMID 39079501 2 citations (OpenAlex) Open-access full textSource: OpenAlex